Oxytocin and addiction: Recent preclinical advances and future clinical potential

Oxytocin, Vasopressin, and Related Peptides in the Regulation of Behavior

Volumn , Issue , 2011, Pages 270-287

  McGregor, Iain S ^a   Bowen, Michael T ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923386164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139017855.018     Document Type: Chapter

References (140)

1. Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Bedogni, G., Caputo, F., Gasbarrini, G., and Landolfi, R. (2011). Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol and Alcoholism, 46, 312-317.
2. Ameisen, O. (2011). High-dose baclofen for suppression of alcohol dependence. Alcoholism, Clinical and Experimental Research, 35, 845-846.
3. Amico, J. A., Vollmer, R. R., Cai, H. M., Miedlar, J. A., and Rinaman, L. (2005). Enhanced initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 289, R1798-806.
4. Anacker, A. M. J. and Ryabinin, A. E. (2010). Biological contribution to social influences on alcohol drinking: evidence from animal models. International Journal of Environmental Research and Public Health, 7, 473-493.
5. Baracz, S. J., Rourke, P. I., Pardey, M. C., Hunt, G. E., McGregor, I. S., and Cornish, J. L. (2012). Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamineinduced conditioend place preference. Behavioural Brain Research, 228, 185-193.
6. Barr, C. S., Dvoskin, R. L., Gupte, M., Sommer, W., Sun, H., Schwandt, M. L., Lindell, S. G., Kasckow, J. W., Suomi, S. J., Goldman, D., Higley, J. D., and Heilig, M. (2009). Functional CRH variation increases stress-induced alcohol consumption in primates. Proceedings of the National Academy of Sciences, 106, 14593-14598.
7. Baskerville, T. A. and Douglas, A. J. (2010). Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. Cns Neuroscience and Therapeutics, 16, e92-e123.
8. Bedi, G., Hyman, D., and De Wit, H. (2010). Is Ecstasy an "empathogen"? Effects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological Psychiatry, 68, 1134-1140.
9. Bedi, G., Phan, K. L., Angstadt, M., and De Wit, H. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology, 207, 73-83.
10. Bowen, M. T., Carson, D. S., Spiro, A., Arnold, J. C., and McGregor, I. S. (2011). Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS One, 6, e27237.
11. Broadbear, J. H., Tunstall, B., and Beringer, K. (2011). Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat. Addiction Biology, 16, 202-214.
12. Budisavljevic, M. N., Stewart, L., Sahn, S. A., and Ploth, D. W. (2003). Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse. American Journal of theMedical Sciences, 326, 89-93.
13. Butovsky, E., Juknat, A., Elbaz, J., Shabat-Simon, M., Eilam, R., Zangen, A., Altstein, M., and Vogel, Z. (2006). Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas. Molecular and Cellular Neurosciences, 31, 795-804.
14. Caputo, F. (2011). Gamma-hydroxybutyrate (GHB) for the treatment of alcohol dependence: a call for further understanding. Alcohol and Alcoholism, 46, 3.
15. Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., and McGregor, I. S. (2010a). Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamineseeking behaviour in rats. Neuropharmacology, 58, 38-43.
16. Carson, D. S., Hunt, G. E., Guastella, A. J., Barber, L., Cornish, J. L., Arnold, J. C., Boucher, A. A., and McGregor, I. S. (2010b). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology, 15, 448-463.
17. Chaviaras, S., Mak, P., Ralph, D., Krishnan, L., and Broadbear, J. H. (2010). Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology, 210, 35-43.
18. Chen, C., Lin, S., Sham, P., Ball, D., Loh, E., Hsiao, C., Chiang, Y., Ree, S., Lee, C., and Murray, R. (2003). Premorbid characteristics and co-morbidity of methamphetamine users with and without psychosis. PsychologicalMedicine, 33(8), 1407-1414.
19. Cornish, J. L., Shahnawaz, Z., Thompson, M. R., Wong, S., Morley, K. C., Hunt, G. E., and McGregor, I. S. (2003). Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. European Journal of Pharmacology, 482, 339-341.
20. Cui, S. S., Bowen, R. C., Gu, G. B., Hannesson, D. K., Yu, P. H., and Zhang, X. (2001). Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. Journal of Neuroscience, 21, 9867-9876.
21. Darke, S., Williamson, A., Ross, J., Teesson, M., and Lynskey, M. (2004). Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 74, 77-83.
22. Dawe, S., Davis, P., Lapworth, K., and Mcketin, R. (2009). Mechanisms underlying aggressive and hostile behavior in amphetamine users. Current Opinion in Psychiatry, 22, 269-273.
23. De Souza Villa, P., Menani, J. V., De Arruda Camargo, G. M., De Arruda Camargo, L. A., and Saad, W. A. (2008). Activation of the serotonergic 5-HT1A receptor in the paraventricular nucleus of the hypothalamus inhibits water intake and increases urinary excretion inwater-deprived rats. Regulatory Peptides, 150, 14-20.
24. Dumont, G. J., Sweep, F., Van Der Steen, R., Hermsen, R., Donders, A. R. T., Touw, D. J., Van Gerven, J. M. A., Buitelaar, J. K., and Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Social Neuroscience, 4, 359-366.
25. Edwards, S. and Self, D. W. (2006). Monogamy: dopamine ties the knot. Nature Neuroscience, 9, 7-8.
26. Emiliano, A. B., Cruz, T., Pannoni, V., and Fudge, J. L. (2006). The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: A substrate for SSRIs therapeutic effects?Neuropsychopharmacology, 32, 977-988.
27. Fasano, A. and Petrovic, I. (2010). Insights into pathophysiology of punding reveal possible treatment strategies. Molecular Psychiatry, 15, 560-573.
28. Garbutt, J. C., Kampov-Polevoy, A. B., Gallop, R., Kalka-Juhl, L., and Flannery, B. A. (2010). Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcoholism, Clinical and Experimental Research, 34, 1849-1857.
29. Geldenhuys, F. G., Sonnendecker, E. W. W., and De Klerk, M. C. C. (1968). Experience with sodium-gamma-4-hydroxybutyric acid (gamma-OH) in obstetrics. Journal of Obstetrics and Gynaecology of the British Commonwealth, 75, 405-413.
30. Gescheidt, T. and Bares, M. (2011). Impulse control disorders in patients with Parkinson's disease. Acta Neurologica Belgica, 111, 3-9.
31. Gibbens, G. L. and Chard, T. (1976). Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration. American Journal of Obstetrics and Gynecology, 126, 243-246.
32. Gimpl, G. and Fahrenholz, F. (2001). The oxytocin receptor system: structure, function, and regulation. Physiological Reviews, 81, 629-683.
33. Goodson, J. L., Schrock, S. E., Klatt, J. D., Kabelik, D., and Kingsbury, M. A. (2009). Mesotocin and nonapeptide receptors promote estrildid flocking behavior. Science, 325, 862-866.
34. Grippo, A. J., Trahanas, D.M., Zimmerman, R. R., Ii, Porges, S. W., and Carter, C. S. (2009). Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology, 34, 1542-1553.
35. Hargreaves, G. A., Hunt, G. E., Cornish, J. L., and McGregor, I. S. (2007).High ambient temperature increases 3,4-methylenedioxymethamphetamine-(MDMA, "ecstasy") induced Fos expression in a region-specific manner. Neuroscience, 145, 764-774.
36. Hargreaves, G. A. and McGregor, I. S. (2007). Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcoholism, Clinical and Experimental Research, 31, 1900-1907.
37. Heilig, M. and Koob, G. F. (2007a). A key role for corticotropin-releasing factor in alcohol dependence. Trends in Neurosciences, 30, 399-406.
38. Heilig, M. and Koob, G. F. (2007b). A key role for corticotropin-releasing factor in alcohol dependence. Trends in Neurosciences, 30, 399-406.
39. Hicks, C., Jorgensen, W., Brown, C., Fardell, J., Koehbach, J., Gruber, C. W., Kassiou, M., Hunt, G. E., and McGregor, I. S. (2012). The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor-Binding Profile, Prosocial Effects and Distribution of c-Fos Expression in Adolescent Rats. Journal of Neuroendocrinology, 24, 1012-1029.
40. Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., Decaria, C. M., Aronowitz, B. R., and Mosovich, S. (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology, 28, 193-198.
41. Holst, S., Uvnas-Moberg, K., and Petersson, M. (2002). Postnatal oxytocin treatment and postnatal stroking of rats reduce blood pressure in adulthood. Autonomic Neuroscience-Basic and Clinical, 99, 85-90.
42. Huber, D., Veinante, P., and Stoop, R. (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science, 308, 245-248.
43. Hunt, G. E., McGregor, I. S., Cornish, J. L., and Callaghan, P. D. (2011). MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonistWAY 100635. Brain Research Bulletin, 86, 65-73.
44. Ibragimov, R., Kovacs, G. L., Szabo, G., and Telegdy, G., (1987). Microinjection of oxytocin into limbicmesolimbic brain structures disrupts heroin selfadministration behavior: a receptor-mediated event? Life Sciences, 41, 1265-1271.
45. Jodogne, C., Tirelli, E., Klingbiel, P., and Legros, J. J. (1991). Oxytocin attenuates tolerance not only to the hypothermic but also to the myroelaxant and akinesic effects of ethanol in mice. Pharmacology, Biochemistry and Behavior, 40, 261-265.
46. Kirilly, E., Benko, A., Ferrington, L., Ando, R. D., Kelly, P. A., and Bagdy, G. (2006). Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats. International Journal of Neuropsychopharmacology, 9, 63-76.
47. Kita, I., Yoshida, Y., and Nishino, S. (2006). An activation of parvocellular oxytocinergic neurons in the paraventricular nucleus in oxytocin-induced yawning and penile erection. Neuroscience Research, 54, 269-275.
48. Klavir, O., Flash, S., Winter, C., and Joel, D. (2009). High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats. Experimental Neurology, 215, 101-109.
49. Koerner, B. I. (2010). Secret of AA: After 75 years, we don't know how it works. Wired, June 23.
50. Kovacs, G. L., Sarnyai, Z., Babarczi, E., Szabo, G., and Telegdy, G. (1990). The role of oxytocin dopamine interactions in cocaine-induced locomotor activity. Neuropharmacology, 29, 365-368.
51. Kovacs, G. L., Sarnyai, Z., and Szabo, G. (1998). Oxytocin and addiction: a review. Psychoneuroendocrinology, 23, 945-962.
52. Kovacs, G. L. and Van Ree, J. M. (1985). Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sciences, 37, 1895-1900.
53. Kovacs, G.L., Laczi, F., Vecsernyes, M., Hódi, K., Telegdy, G., and László, F. (1987). Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence. Experimental Brain Research, 65, 307-311.
54. Kramer, K. M., Choe, C., Carter, C. S., and Cushing, B. S. (2006).Developmental effects of oxytocin on neural activation and neuropeptide release in response to social stimuli. Hormones and Behavior, 49, 206-214.
55. Krause, E. G., De Kloet, A. D., Flak, J. N., Smeltzer, M. D., Solomon, M. B., Evanson, N. K., Woods, S. C., Sakai, R. R., and Herman, J. P. (2011). Hydration state controls stress responsiveness and social behavior. Journal of Neuroscience, 31, 5470-5476.
56. Langle, S. L., Poulain, D. A., and Theodosis, D. T. (2003). Induction of rapid, activity-dependent neuronal-glial remodelling in the adult rat hypothalamus in vitro. European Journal of Neuroscience, 18, 206-214.
57. Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., and Koenig, J. I. (2005). Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology, 30, 1883-1894.
58. Lee, Y., Hamamura, T., Ohashi, K., Fujiwara, Y., and Kuroda, S. (1999). The effect of lithium on methamphetamineinduced regional Fos protein expression in the rat brain. Neuroreport, 10, 895-900.
59. Legros, J.-J. (2001). Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones? Psychoneuroendocrinology, 26, 649-655.
60. Leone, M. A., Vigna-Taglianti, F., Avanzi, G., Brambilla, R., and Faggiano, F. (2010). Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database of Systematic Reviews, CD006266.
61. Liberzon, I., Trujillo, K. A., Akil, H., and Young, E. A. (1997). Motivational properties of oxytocin in the conditioned place preference paradigm. Neuropsychopharmacology, 17, 353-359.
62. Liu, J. and Wang, L. (2011). Baclofen for alcohol withdrawal. Cochrane Database of Systematic Reviews, CD008502.
63. Logrip, M. L., Koob, G. F., and Zorrilla, E. P. (2011). Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs, 25, 271-287.
64. Ludwig, M. and Leng, G. (2006). Dendritic peptide release and peptide-dependent behaviours. Nature Reviews. Neuroscience, 7, 126-136.
65. Lukas, M., Bredewold, R., Neumann, I. D., and Veenema, A. H. (2010). Maternal separation interferes with developmental changes in brain vasopressin and oxytocin receptor binding in male rats. Neuropharmacology, 58, 78-87.
66. Lukas, M., Toth, I., Reber, S. O., Slattery, D. A., Veenema, A. H., and Neumann, I. D. (2011). The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology, DOI: 10.1038/npp.2011.95.
67. Macdonald, E., Dadds, M. R., Brennan, J. L., Williams, K., Levy, F., and Cauchi, A. J. (2011). A review of safety, sideeffects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology, 36, 1114-1126.
68. Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M. L., Fontaine, D., Du Montcel, S. T., Yelnik, J., Chereau, I., Arbus, C., Raoul, S., Aouizerate, B., Damier, P., Chabardes, S., Czernecki, V., Ardouin, C., Krebs, M. O., Bardinet, E., Chaynes, P., Burbaud, P., Cornu, P., Derost, P., Bougerol, T., Bataille, B., Mattei, V., Dormont, D., Devaux, B., Verin, M., Houeto, J. L., Pollak, P., Benabid, A. L., Agid, Y., Krack, P., Millet, B., and Pelissolo, A. (2008). Subthalamic nucleus stimulation in severe obsessivecompulsive disorder. New England Journal of Medicine, 359, 2121-2134.
69. Marvin, E., Scrogin, K., and Dudas, B. (2010). Morphology and distribution of neurons expressing serotonin 5-HT1A receptors in the rat hypothalamus and the surrounding diencephalic and telencephalic areas. Journal of Chemical Neuroanatomy, 39, 235-241.
70. Matsuoka, T., Sumiyoshi, T., Tanaka, K., Tsunoda, M., Uehara, T., Itoh, H., and Kurachi, M. (2005). NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia. Brain Research, 1053, 131-136.
71. McGregor, I. S., Callaghan, P. D., and Hunt, G. E. (2008). From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? British Journal of Pharmacology, 154, 358-368.
72. McGregor, I. S., Gurtman, C. G., Morley, K. C., Clemens, K. J., Blokland, A., Li, K.M., Cornish, J. L., andHunt, G. E. (2003). Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-termoutcomes. Psychopharmacology, 168, 465-474.
73. McMurray, M. S., Williams, S. K., Jarrett, T. M., Cox, E. T., Fay, E. E., Overstreet, D. H., Walker, C. H., and Johns, J. M. (2008). Gestational ethanol and nicotine exposure: effects on maternal behavior, oxytocin, and offspring ethanol intake in the rat. Neurotoxicology and Teratology, 30, 475-486.
74. Melis, M. R. and Argiolas, A. (2011). Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid inmale rats. Neuroscience and Biobehavioral Reviews, 35, 939-955.
75. Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., and Doblin, R. (2011). The safety and efficacy of +/-3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant post-traumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25, 439-452.
76. Montagnese, C., Poulain, D. A., and Theodosis, D. T. (1990). Influence of ovarian steroids on the ultrastructural plasticity of the adult rat supraoptic nucleus induced by central administration of oxytocin. Journal of Neuroendocrinology, 2, 225-231.
77. Morley, K. C., Gallate, J. E., Hunt, G. E., Mallet, P. E., and McGregor, I. S. (2001). Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology, 433, 91-99.
78. Morley, K. C. and McGregor, I. S. (2000). (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. European Journal of Pharmacology, 408, 41-49.
79. Motbey, C. P., Hunt, G. E., Bowen, M. T., Artiss, S., and McGregor, I. S. (2011). Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addiction Biology, DOI: 10.1111/j.1369-1600.2011.00384.x.
80. Neumann, I. D. (2007). Stimuli and consequences of dendritic release of oxytocin within the brain. Biochemical Society Transactions, 35, 1252-1257.
81. Neumann, I. D., Torner, L., Toschi, N., and Veenema, A. H. (2006). Oxytocin actions within the supraoptic and paraventricular nuclei: differential effects on peripheral and intranuclear vasopressin release. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 291, R29-36.
82. O'Shea, M., McGregor, I. S., and Mallet, P. E. (2006). Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology, 20, 611-621.
83. O'Shea, M., Singh, M. E., McGregor, I. S., and Mallet, P. E. (2004). Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology, 18, 502-508.
84. Olson, B. R., Drutarosky, M. D., Chow, M.-S., Hruby, V. J., Stricker, E.M., and Verbalis, J. G. (1991). Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides, 12, 113-118.
85. Pallanti, S., Bernardi, S., Raglione, L. M., Marini, P., Ammannati, F., Sorbi, S., and Ramat, S. (2010). Complex repetitive behavior: punding after bilateral subthalamic nucleus stimulation in Parkinson's disease. Parkinsonism and Related Disorders, 16, 376-380.
86. Parrott, A. C. (2004). MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology, 50, 329-335.
87. Pedersen, C. A., Smedley, K. L., Leserman, J., Jarskog, L. F., Rau, S. W., Kampov-Polevoi, A., Casey, R. L., Fender, T., and Garbutt, J. C. (2012). Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcoholism: Clinical and Experimental Research, DOI: 10.1111/j.1530-0277.2012.01958.x.
88. Pedraza, C., Davila, G., Martin-Lopez, M., and Navarro, J. F. (2007). Anti-aggressive effects of GHB in OF.1 strain mice: Involvement of dopamine D(2) receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 337-342.
89. Petersson, M., Alster, P., Lundeberg, T., and Uvnäs-Moberg, K. (1996). Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neuroscience Letters, 212, 87-90.
90. Petersson, M., Hulting, A.-L., and Uvnäs-Moberg, K. (1999). Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neuroscience Letters, 264, 41-44.
91. Popeski, N. and Woodside, B. (2001). Effect of nitric oxide synthase inhibition on fos expression in the hypothalamus of female rats following central oxytocin and systemic urethane administration. Journal of Neuroendocrinology, 13, 596-607.
92. Porges, S. W. (2003). Social engagement and attachment: a phylogenetic perspective. Annals of the New York Academy of Sciences, 1008, 31-47.
93. Qi, J., Yang, J. Y., Song, M., Li, Y., Wang, F., and Wu, C. F. (2008). Inhibition by oxytocin of methamphetamineinduced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 376, 441-448.
94. Qi, J., Yang, J. Y., Wang, F., Zhao, Y. N., Song, M., and Wu, C. F. (2009). Effects of oxytocin on methamphetamineinduced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology, 56, 856-865.
95. Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., Matsuda-Matsumoto, H., Iwazaki, T., and McGregor, I. S. (2008). Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology, 33, 1113-1126.
96. Ring, R. H., Schechter, L. E., Leonard, S. K., Dwyer, J. M., Platt, B. J., Graf, R., Grauer, S., Pulicicchio, C., Resnick, L., Rahman, Z., Sukoff Rizzo, S. J., Luo, B., Beyer, C. E., Logue, S. F., Marquis, K. L., Hughes, Z. A., and Rosenzweig-Lipson, S. (2010). Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology, 58, 69-77.
97. Rossoni, E., Feng, J., Tirozzi, B., Brown, D., Leng, G., and Moos, F. (2008). Emergent synchronous bursting of oxytocin neuronal network. PLoS Computational Biology, 4, e1000123.
98. Rotzinger, S., Lovejoy, D. A., and Tan, L. A. (2010). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides, 31, 736-756.
99. Russell, J. A., Gosden, R. G., Humphreys, E. M., Cutting, R., Fitzsimons, N., Johnston, V., Liddle, S., Scott, S., and Stirland, J. A. (1989). Interruption of parturition in rats by morphine: a result of inhibition of oxytocin secretion. Journal of Endocrinology, 121, 521-536.
100. Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., Parolaro, D., Nishimori, K., Parenti, M., and Chini, B. (2011). Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biological Psychiatry, 69, 875-882.
101. Sanbe, A., Takagi, N., Fujiwara, Y., Yamauchi, J., Endo, T., Mizutani, R., Takeo, S., Tsujimoto, G., and Tanoue, A. (2008). Alcohol preference in mice lacking the Avpr1a vasopressin receptor. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 294, R1482-1490.
102. Sarnyai, Z. (1998). Oxytocin and neuroadptation to cocaine. In: Urban, I., Burbach, J., and Wied, D. (eds.), Advances in Brain Vasopressin. Amsterdam, TheNetherlands: Elsevier Science.
103. Sarnyai, Z. (2011). Oxytocin as a potential mediator and modulator of drug addiction. Addiction Biology, 16, 199-201.
104. Sarnyai, Z. and Kovacs, G. L. (1994). Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology, 19, 85-117.
105. Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., and Legros, J. J. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32, 407-410.
106. Schaller, F., Watrin, F., Sturny, R., Massacrier, A., Szepetowski, P., and Muscatelli, F. (2010). A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. Human Molecular Genetics, 19, 4895-4905.
107. Schmidt-Mutter, C., Pain, L., Sandner, G., Gobaille, S., and Maitre, M. (1998). The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. European Journal of Pharmacology, 342, 21-27.
108. Silva, S. M., Madeira, M. D., Ruela, C., and Paula-Barbosa, M. M. (2002). Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. Brain Research, 925, 76-88.
109. Sivukhina, E. V., Dolzhikov, A. A., Morozov, I. E., Jirikowski, G. F., and Grinevich, V. (2006). Effects of chronic alcoholic disease on magnocellular and parvocellular hypothalamic neurons in men. Hormone and Metabolic Research, 38, 382-390.
110. Slattery, D. A. and Neumann, I. D. (2008). No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. Journal of Physiology, 586, 377-385.
111. Slattery, D. A. and Neumann, I. D. (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bredWistar rats. Neuropharmacology, 58, 56-61.
112. Subramanian, M. G. (1999). Alcohol inhibits sucklinginduced oxytocin release in the lactating rat. Alcohol, 19, 51-55.
113. Sumnall, H. R., Woolfall, K., Edwards, S., Cole, J. C., and Beynon, C.M. (2008).Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence, 92, 286-290.
114. Szabo, G., Kovacs, G. L., and Telegdy, G. (1987). Effects of neurohypophyseal peptide hormones on alcohol dependence and withdrawal. Alcohol and Alcoholism, 22, 71-74.
115. Theodosis, D. T. (2002). Oxytocin-secreting neurons: A physiologicalmodel of morphological neuronal and glial plasticity in the adult hypothalamus. Frontiers in Neuroendocrinology, 23, 101-135.
116. Theodosis, D. T., Montagnese, C., Rodriguez, F., Vincent, J. D., and Poulain, D. A. (1986). Oxytocin induces morphological plasticity in the adult hypothalamoneurohypophysial system. Nature, 322, 738-740.
117. Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., and McGregor, I. S. (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience, 146, 509-514.
118. Thompson, M. R., Callaghan, P. D., Hunt, G. E., andMcGregor, I. S. (2008). Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 1013-1021.
119. Thompson, M. R., Hunt, G. E., and McGregor, I. S. (2009). Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats. Social Neuroscience, 4, 60-72.
120. Thompson, M. R., Li, K. M., Clemens, K. J., Gurtman, C. G., Hunt, G. E., Cornish, J. L., and McGregor, I. S. (2004). Chronic fluoxetine treatment partly attenuates the longterm anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology, 29, 694-704.
121. Tirelli, E., Jodogne, C., and Legros, J. J. (1992). Oxytocin blocks the environmentally conditioned compensatory response present after tolerance to ethanol-induced hypothermia in mice. Pharmacology, Biochemistry and Behavior, 43, 1263-1267.
122. Uvnas-Moberg, K. (1998a). Antistress pattern induced by oxytocin. News in Physiological Sciences, 13, 22-25.
123. Uvnas-Moberg, K. (1998b). Oxytocin maymediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology, 23, 819-835.
124. Uvnas-Moberg, K., Bjokstrand, E., Hillegaart, V., and Ahlenius, S. (1999). Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology, 142, 95-101.
125. Uvnas-Moberg, K., Bruzelius, G., Alster, P., and Lundeberg, T. (1993). The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. Acta Physiologica Scandinavica, 149, 199-204.
126. Uvnas-Moberg, K., Hillegaart, V., Alster, P., and Ahlenius, S. (1996). Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat. Neuropharmacology, 35, 1635-1640.
127. Vaccari, C., Lolait, S. J., and Ostrowski, N. L. (1998). Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology, 139, 5015-5033.
128. Van Nieuwenhuijzen, P., McGregor, I., and Hunt, G. (2009). The distribution of [gamma]-hydroxybutyrate-induced Fos expression in rat brain: Comparison with baclofen. Neuroscience, 158, 441-455.
129. Van Nieuwenhuijzen, P. S., Long, L. E., Hunt, G. E., Arnold, J. C., and McGregor, I. S. (2010). Residual social, memory and oxytocin-related changes in rats following repeated exposure to gamma-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology, 212, 663-674.
130. Verty, A. N. A., Mcfarlane, J. R., McGregor, I. S., and Mallet, P. E. (2004). Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology, 47, 593-603.
131. Volkow, N. D., Baler, R. D., and Goldstein, R. Z. (2011). Addiction: pulling at the neural threads of social behaviors. Neuron, 69, 599-602.
132. Williams, S. K., Cox, E. T., McMurray, M. S., Fay, E. E., Jarrett, T. M., Walker, C. H., Overstreet, D. H., and Johns, J. M. (2009). Simultaneous prenatal ethanol and nicotine exposure affect ethanol consumption, ethanol preference and oxytocin receptor binding in adolescent and adult rats. Neurotoxicology and Teratology, 31, 291-302.
133. Windle, R. J., Kershaw, Y. M., Shanks, N., Wood, S. A., Lightman, S. L., and Ingram, C. D. (2004). Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. Journal of Neuroscience, 24, 2974-2982.
134. Winstock, A. R., Lea, T., and Copeland, J. (2009). Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. Journal of Psychopharmacology, 23, 84-93.
135. Witt, D. M., Winslow, J. T., and Insel, T. R. (1992). Enhanced social interaction in rats following chronic, centrally infused oxytocin. Pharmacology, Biochemistry and Behavior, 43, 855-861.
136. Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., and Aitchison, K. J. (2006). Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. Journal of Psychopharmacology, 20, 400-410.
137. Yang, J. Y., Qi, J., Han, W. Y., Wang, F., and Wu, C. F. (2010). Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission. Acta Pharmacologica Sinica, 31, 1071-1074.
138. You, Z. D., Li, J. H., Song, C. Y., Lu, C. L., and He, C. (2001). Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats. Neuroscience Research, 41, 143-150.
139. You, Z. D., Li, J. H., Song, C. Y., Wang, C. H., and Lu, C. L. (2000). Chronic morphine treatment inhibits oxytocin synthesis in rats. Neuroreport, 11, 3113-3116.
140. Young, K. A., Gobrogge, K. L., Liu, Y., and Wang, Z. (2011). The neurobiology of pair bonding: insights from a socially monogamous rodent. Frontiers in Neuroendocrinology, 32, 53-69.